- Constellation Software‘s earnings per share (EPS) for the fourth quarter were $13.44, which was below the estimated $13.72.
- EPS for the same period last year was $6.65, indicating significant growth.
- The company’s revenue for the quarter was $2.70 billion, marking a 16% increase compared to the previous year.
- This revenue figure was slightly below the expected $2.73 billion.
- Cash flows from operations in the fourth quarter were $678 million, showing a substantial 33% rise from the previous year.
- Analyst ratings for Constellation Software include 7 buys, 4 holds, and 1 sell.
“`
A look at Constellation Software Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Constellation Software Inc, a software holding company focusing on acquiring mission-critical, vertical market software companies, appears to have a positive long-term outlook based on the Smartkarma Smart Scores. With a strong score of 4 in Growth and Momentum, the company seems well-positioned for future expansion and market performance. The high Growth score indicates potential for increasing market share and profitability, while the Momentum score suggests sustained positive performance trends.
While Constellation Software scores lower in Value, Dividend, and Resilience with scores of 2 across these categories, the higher scores in Growth and Momentum may overshadow these aspects in terms of long-term prospects. Overall, the company’s strategic focus on acquiring and nurturing software firms in critical markets bodes well for its growth trajectory in the coming years.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
